XML 57 R41.htm IDEA: XBRL DOCUMENT v3.25.0.1
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
11 Months Ended 12 Months Ended
May 02, 2024
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Derivative Instruments          
Allowance for credit loss on the purchased credit deteriorated assets   $ 0 $ 3,200,000    
Concentration of Credit Risk          
Expense for bad debts     1,938,000 $ 1,808,000  
Deductions from allowance for doubtful accounts, net of recoveries     $ 700,000 1,100,000 $ 400,000
Inventories          
Percentage of LIFO Inventory   30.00% 30.00%    
Cost valuation of inventory if FIFO had been used exclusively   $ 7,600,000 $ 7,600,000 8,600,000  
LIFO inventories increased (decreased) cost of sales     500,000 200,000 800,000
Property, Plant and Equipment          
Depreciation expense     23,000,000 16,200,000 15,000,000
Cash and Cash Equivalents          
Increased (reduced) cash used for capital expenditures     (1,200,000) 700,000 (600,000)
Investments [Abstract]          
Pre-tax impairment loss         600,000
Selling Expense [Member]          
Concentration of Credit Risk          
Expense for bad debts     $ 1,900,000 1,800,000 $ 500,000
Maximum [Member] | Performance-Based Restricted Stock Units [Member]          
Stock Based Compensation          
Percentage of established target performance criteria     250.00%    
Maximum [Member] | Sales [Member] | Customer Concentration Risk [Member]          
Concentration of Credit Risk          
Concentration risk percentage     10.00%    
Minimum [Member] | Performance-Based Restricted Stock Units [Member]          
Stock Based Compensation          
Percentage of established target performance criteria     0.00%    
Interest Rate Swap [Member]          
Derivative Instruments          
Derivative, Notional Amount $ 200,000,000 192,500,000 $ 192,500,000    
Fair value, interest rate swap   3,200,000 3,200,000    
Net interest rate swap gains     (3,200,000)    
Gains expected to be reclassfied     (800,000)    
Maturity date Jan. 31, 2029        
Debt effective rate 4.606%        
Other Current Assets [Member] | Interest Rate Swap [Member]          
Derivative Instruments          
Fair value, interest rate swap   700,000 700,000    
Other Noncurrent Liabilities [Member] | Interest Rate Swap [Member]          
Derivative Instruments          
Fair value, interest rate swap   $ 2,500,000 $ 2,500,000    
Estimate of Fair Value, Fair Value Disclosure [Member] | Less unamortized deferred financing fees [Member]          
Organization Consolidation And Presentation Of Financial Statements [Line Items]          
Notes payable, fair value disclosure       $ 37,800,000